BUGA-CoL Hydrolyzed Type II Collagen from Chicken Sternum, Lyophilized
Product Information
BUGA-CoL Hydrolyzed Type II Collagen from Chicken Sternum, Lyophilized (BUGA-HydroCol-II) is derived from chicken sternum cartilage sourced from certified organizations that comply with the Turkish Food Codex, food safety, and quality standards. BUGA-HydroCol-II is manufactured under GMP conditions. The product is a hydrolyzed type II collagen of medical-grade purity.
BUGA-HydroCol-II is a form of type II collagen that has been broken down into peptides through enzyme/acid treatment. It dissolves easily in pure water and is rapidly absorbed. For this reason, it is frequently preferred in dietary supplements for skin and joint health. The product is offered in a lyophilized powder form, packaged in user-friendly containers.
• Biomaterial Design
• Joint Health
• Osteoarthritis Treatment
• Cartilage Repair
• Dietary Supplements
• Inflammation Reduction
• Weigh the required amount of BUGA-HydroCol-II product.
• Dissolve the product in the desired volume of pure water to achieve your desired concentration.
• Stir the mixture at room temperature using a magnetic stirrer at 150 rpm.
• BUGA-HydroCol-II will easily dissolve in pure water. Once fully dissolved, you can use the solution as needed or store it at +4 ºC.
Technical Specifications of the Product
Appearance | Lyophilized white powder |
Smell | Odorless |
Extraction method | Enzymatic |
Solubility/Collagen concentration | Pure water |
Storage temperature | 2-8 ºC |
Shelf life | 2 years from date of production |
Solution shelf life | 3 months after being put into solution (at +4 ºC) |
Source (Animal type) | Chicken Sternum |
Total protein content (100g) | 11,4 g |
SDS PAGE (molecular weight and impurity determination) | <50 kDa |
• Kumar, P., Bansal, P., Rajnish, R. K., Sharma, S., Dhillon, M. S., Patel, S., & Kumar, V. (2023). Efficacy of undenatured collagen in knee osteoarthritis: review of the literature with limited meta-analysis. American Journal of Translational Research, 15(9), 5545.
• Luo, C., Su, W., Song, Y., & Srivastava, S. (2022). Efficacy and safety of native type II collagen in modulating knee osteoarthritis symptoms: a randomised, double‐blind, placebo‐controlled trial. Journal of Experimental Orthopaedics, 9(1), 123.
• Sadigursky, D., Sanches, M. M., Garcia, N. M., de Oliveira Cantão, M., & Matos, M. A. (2023). Effectiveness of the use of non-hydrolysed type II collagen in the treatment of osteoarthritis: a systematic review and meta-analysis. Brazilian Journal of Health Review, 6(1), 1649-1660.
• Wang, H. (2021). A review of the effects of collagen treatment in clinical studies. Polymers, 13(22), 3868.
